PTC Therapeutics logo

PTC Therapeutics

ID: 1853020

A biopharmaceutical company focused on discovery and development of small-molecule drugs to treat genetic and rare diseases.

4

Funding Rounds

$222.0m

Money raised

Overview

A biopharmaceutical company focused on discovery and development of small-molecule drugs to treat genetic and rare diseases.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company PTC Therapeutics has raised a total of $81.1m in funding over 4 rounds.

Key Insights:

  • PTC Therapeutics funding round, May 2013: $4.5m
  • PTC Therapeutics Series E round: $50m
  • PTC Therapeutics funding round, November 2005: $26.6m
  • PTC THERAPEUTICS, INC. funding round, May 2020: $140.95m

Subsidiaries

PTC Therapeutics operates through the following subsidiaries: